Nuclear receptor 4A1 (NR4A1) antagonists induce ROS-dependent inhibition of mTOR signaling in endometrial cancer.

Gynecol Oncol

Department of Veterinary Physiology and Pharmacology, Texas AM University, College Station, TX 77843, USA. Electronic address:

Published: July 2019

Objectives: NR4A1 is overexpressed in many solid tumors, and the objectives of this study were to investigate the expression and functional role of this receptor in endometrial cancer cells and demonstrate that NR4A1 antagonist inhibit mTOR.

Methods: Ishikawa and Hec-1B endometrial cells were used as models to investigate the parallel effects of NR4A1 knockdown by RNA interference (siNR4A1) and treatment with bis-indole-derived NR4A1 ligands (antagonists) on cell growth and survival by determining cell numbers and effects on Annexin V staining. Western blot analysis of whole cell lysates was used to determine effects of these treatments on expression of growth promoting, survival and apoptotic genes and mTOR signaling. Effects of NR4A1 antagonists on tumor growth were determined in athymic nude mice bearing Hec-1B cells as xenografts.

Results: siNR4A1 or treatment with bis-indole-derived NR4A1 antagonists inhibited growth of endometrial cancer cells in vitro and endometrial tumors in vivo and this was accompanied by decreased expression of growth promoting and survival genes and mTOR inhibition.

Conclusions: NR4A1 exhibited pro-oncogenic activity in endometrial cells due, in part, to regulation of cell growth, survival and mTOR signaling, and all of these pathways and their associated gene products were inhibited after treatment with bis-indole-derived NR4A1 antagonists. Moreover, these compounds also blocked endometrial tumor growth in vivo demonstrating that NR4A1 is a potential novel drug target for treatment of endometrial cancer.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6625344PMC
http://dx.doi.org/10.1016/j.ygyno.2019.04.678DOI Listing

Publication Analysis

Top Keywords

nr4a1 antagonists
16
endometrial cancer
16
mtor signaling
12
treatment bis-indole-derived
12
bis-indole-derived nr4a1
12
nr4a1
10
endometrial
8
cancer cells
8
endometrial cells
8
effects nr4a1
8

Similar Publications

This study investigates the neuroprotective potential of STAT3 inhibition in reducing oxidative stress-induced neuronal damage and apoptosis, a major factor contributing to the onset and progression of neurodegenerative diseases, including Alzheimer's disease (AD). Our findings demonstrate that STAT3 inhibitors significantly enhance cell survival and reduce apoptosis in SH-SY5Y cells exposed to hydrogen peroxide. These protective effects are mediated through the ERK/CREB signaling pathway rather than direct suppression of STAT3 phosphorylation.

View Article and Find Full Text PDF

Social isolation is an established risk factor for psychiatric illness, and became increasingly topical with the spread of SARS-CoV-2. We used RNA sequencing (RNA-Seq) to enable unbiased assessment of transcriptomic changes within the prefrontal cortex (PFC) of isolation-reared rats. To provide insight into the relevance of this manipulation for studying human illness, we compared differentially expressed genes (DEGs) and enriched biological functions against datasets involving post-mortem frontal cortical tissue from patients with psychiatric and neurodevelopmental illnesses.

View Article and Find Full Text PDF
Article Synopsis
  • The study focuses on the NR4A1 gene and its impact on osteoporosis and fat cell development (adipogenesis) by examining its role in human bone marrow-derived mesenchymal stem cells (BMD-MSCs).
  • Researchers conducted experiments by either overexpressing or knocking down the NR4A1 gene in different cell lines to observe changes in alkaline phosphatase activity (related to bone formation) and lipid content (related to fat cell formation).
  • Findings showed that NR4A1 knockdown increased bone mineralization and decreased fat cell formation, while overexpression of NR4A1 had the opposite effects, indicating that NR4A1 negatively influences bone formation and positively influences fat cell development through Notch signaling pathways
View Article and Find Full Text PDF

Purpose: The IMMUNOSARC trial combined an antiangiogenic agent (sunitinib) with a PD1 inhibitor (nivolumab) in advanced sarcomas. Here, we present the first correlative studies of the soft-tissue sarcoma cohort enrolled in this trial.

Experimental Design: Formalin-fixed paraffin-embedded and peripheral blood samples were collected at baseline and week 13.

View Article and Find Full Text PDF
Article Synopsis
  • PLX5622 is a small molecular inhibitor that targets the CSF1 receptor, primarily used to deplete macrophages in the central nervous system of C57BL/6 mice.
  • After one week of treatment, it was found to significantly reduce interstitial macrophages in the lungs and brains, leading to decreased infection from the fungus Cryptococcus neoformans.
  • The study highlights that while PLX5622 effectively reduces fungal lung infection, its impact relies on the presence of lymphocytes, as treatment does not alter fungal burden in lymphocyte-deficient mice.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!